Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508

✍ Scribed by Kagami, Yoshitoyo; Itoh, Kuniaki; Tobinai, Kensei; Fukuda, Haruhiko; Mukai, Kiyoshi; Chou, Takaaki; Mikuni, Chikara; Kinoshita, Tomohiro; Fukushima, Noriyasu; Kiyama, Yoshio; Suzuki, Takayo; Sasaki, Tsuneo; Watanabe, Yuko; Tsukasaki, Kunihiro; Hotta, Tomomitsu; Shimoyama, Masanori; Ogura, Michinori

• Book ID: 113099325
• Publisher: Carden Jennings Publishing
• Year: 2012
• Tongue: English
• Weight: 308 KB
• Volume: 96
• Category: Article
• ISSN: 0925-5710
• DOI: 10.1007/s12185-012-1101-2